Process Development for the Care of the Person Under Investigation for Ebola Virus Disease: a Collaboration of Biocontainment Unit and Emergency Medicine Personnel

Patients presenting with epidemiological risk factors for Ebola virus disease (EVD) and symptoms consistent with the disease require screening with a molecular assay. If the initial test is negative, but the patient has been symptomatic for less than 3 days, a follow-up test is required to reliably...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwedhelm, Shelly S., Wadman, Michael C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Ebola Virus Disease: Issues in Preparedness and Clinical Care (A Hewlett, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100528/
https://www.ncbi.nlm.nih.gov/pubmed/32226327
http://dx.doi.org/10.1007/s40506-016-0099-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100528/
https://www.ncbi.nlm.nih.gov/pubmed/32226327
http://dx.doi.org/10.1007/s40506-016-0099-z

Ejemplares similares